4//SEC Filing
Pedulla Denise E 4
Accession 0001077183-20-000209
CIK 0001077183other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 6:00 PM ET
Size
13.7 KB
Accession
0001077183-20-000209
Insider Transaction Report
Form 4
Pedulla Denise E
General Counsel
Transactions
- Sale
Common Stock
2020-11-10$42.00/sh−2,262$95,004→ 56,726 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-11-10−15,000→ 0 totalExercise: $7.85Exp: 2020-12-08→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2020-11-10$7.85/sh+15,000$117,750→ 58,988 total
Holdings
- 25,000
Stock Option (Right to Buy)
Exercise: $7.52Exp: 2022-04-28→ Common Stock (25,000 underlying) - 48,334
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (48,334 underlying) - 17,496
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (17,496 underlying) - 18,757
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (18,757 underlying)
Footnotes (5)
- [F1]On December 8, 2015, Ms. Pedulla was granted 60,000 stock options. These options vested ratably over the first four anniversary dates of the grant date.
- [F2]On April 28, 2017, Ms. Pedulla was granted 75,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F3]On January 26, 2018, Ms. Pedulla was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. Pedulla was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. Pedulla was granted 18,757 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001804602
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 6:00 PM ET
- Size
- 13.7 KB